Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
CV
Strong SellSinkerCapsoVision, Inc. · Healthcare · United States · $297M · Avg Vol: $637K/d
COMPANY DESCRIPTION
CapsoVision, Inc. is a medical device company specializing in the development and commercialization of innovative capsule endoscopy systems for gastrointestinal diagnostics. Its proprietary technology offers a non-invasive method for examining the small bowel, aiming to provide superior imaging capabilities and a more comfortable diagnostic experience for patients.
FINANCIAL SUMMARY (USD)
| Year | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.8M | 11.8M | 13.6M | 17.9% | 13.9M | 14.9M | 19.8M | 20.9% |
| EPS | -0.29 | -0.43 | -1.03 | — | -1.11 | -0.56 | -0.44 | — |
| Shares | 46.3M | 46.3M | 46.9M | +1.1% | 50.0M | — | — | — |
| Debt | 1.5M | 1.2M | 0.9M | -23.5% | 0.7M | — | — | — |
| Equity | -109.8M | -129.5M | 13.3M | — | — | — | — | — |
| Op CF | -10.8M | -20.1M | -22.9M | — | -27.8M | — | — | — |
| Inv CF | -0.8M | -0.2M | -90.0K | — | — | — | — | — |
| Fin CF | 20.5M | 15.1M | 23.6M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CV are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CV | CapsoVision, Inc.(you) | $297M | 13 | Strong Sell |
| CATX | Perspective Therapeutics, Inc. | $355M | 12 | Strong Sell |
| RXST | RxSight, Inc. | $293M | 19 | Strong Sell |
| TLSI | TriSalus Life Sciences, Inc. | $297M | 20 | Strong Sell |
| MOBI | Mobia Medical, Inc. | $378M | 15 | Strong Sell |
| LAB | Standard BioTools Inc. | $252M | 18 | Strong Sell |
| PACB | Pacific Biosciences of California, Inc. | $435M | 16 | Strong Sell |
| PAIN.V | Vector Science and Therapeutics Corp. | $233M | 8 | Strong Sell |
| CLPT | ClearPoint Neuro, Inc. | $474M | 10 | Strong Sell |
| QSI | Quantum-Si incorporated | $171M | 11 | Strong Sell |
Peer medians: ROE -30.5% · P/E 27.0x · Gross margin 58.3%